Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Cardiology · Myocardial Infarction

Missed Antiplatelet Dose After a Heart Attack or Stent?

At a Glance

After missing an antiplatelet dose following a heart attack or stent, do not double the next dose or stop treatment on your own. Check the exact medicine instructions and contact a pharmacist or cardiology team; call 911 for heart attack or severe bleeding symptoms.

If you realize you missed a dose of your antiplatelet medication, do not panic and do not automatically take a double dose to catch up [1]. A single missed dose is important, but it does not mean a blood clot is instantly forming. Because instructions differ by the specific drug (such as aspirin, clopidogrel, ticagrelor, or prasugrel) and whether it is taken once or twice a day [2], you must check your exact medication label or call a pharmacist for instructions [3]. Never take an extra pill, substitute drugs, or try to “catch up” on your own [4].

What To Do Right Now (Single Missed Dose)

  1. Do not take a double dose: Do not take two pills at once [1].
  2. Identify the timing: Figure out exactly how many hours it has been since you were supposed to take the pill.
  3. Check your specific label: Look at the patient information leaflet for your exact drug. Medications taken once a day have different missed-dose windows than those taken twice a day [2].
  4. Call for help if unsure: If you do not have the leaflet, call your local pharmacy.

If you have already taken an extra dose by mistake: Contact your pharmacist, prescribing team, or local poison control center immediately for individualized advice. Do not skip your next routine dose without professional instruction [1].

If You Missed Multiple Doses or Cannot Get Your Medication

If you have missed more than one dose, run out of medication, or cannot afford a refill, do not wait for your next routine appointment.

  • During business hours: Call your prescribing doctor or cardiology team immediately [5].
  • After hours: Call the cardiology office’s on-call service or an urgent care clinic.
  • Refill problems: Speak to a pharmacist. They can sometimes provide an emergency supply or help contact the on-call doctor.

Do not borrow someone else’s medication, do not switch between different antiplatelets, and do not try to make up for missed doses by taking over-the-counter painkillers or supplements.

Why Interrupting Therapy is Dangerous

Antiplatelet medications keep your blood cells (platelets) from clumping together [6]. After a heart attack or the placement of a stent (a small mesh tube used to keep a blocked artery open), you are usually prescribed dual antiplatelet therapy (DAPT)—meaning you take aspirin alongside a second antiplatelet drug [7].

Taking these exactly as prescribed is critical for preventing stent thrombosis, a highly dangerous complication where a clot forms inside the stent [8]. While one missed dose does not cause an immediate heart attack, interrupting your medication—especially early after your procedure—significantly increases your risk of serious complications [9][10].

Important: The length of time you need to take DAPT is personalized based on your specific heart history, bleeding risk, and stent type [11]. Never assume it is safe to stop just because a few months have passed.

Procedures, Dental Work, and Side Effects

Never pause your aspirin or P2Y12 inhibitor solely on the advice of a dentist or surgeon, or because you are experiencing minor bruising [1]. Stopping early can be dangerous [8]. Any planned procedure or medication interruption must be coordinated directly with your cardiology team.

When to Seek Emergency Medical Help

If you experience warning signs of a heart attack or major bleeding, do not wait for a medication callback. Call 911 or your local emergency number immediately. Do not drive yourself to the hospital. Note that emergency symptoms warrant urgent care whether or not you have missed a dose.

Signs of a Heart Attack (Stent Thrombosis):

  • New or returning chest pain, pressure, or tightness [12]
  • Pain or discomfort spreading to the arm, shoulder, back, neck, or jaw
  • Shortness of breath or difficulty breathing [13]
  • Cold sweating (diaphoresis) or unusual fatigue [13]
  • Fainting, dizziness, or extreme weakness [14]
  • (Note: A heart attack can occur without classic chest pain.)

Signs of Severe Bleeding:

  • Vomiting blood or coughing up blood [15]
  • Black, tarry stools or blood in your urine [16]
  • Sudden, severe headache or stroke warning signs (such as facial drooping, new arm weakness, or trouble speaking)

Tips for Never Missing a Dose

  • Routines and Alarms: Take your medicine exactly at the prescribed interval (for example, ticagrelor is typically taken twice daily, while clopidogrel is once daily) [2]. Set phone alarms.
  • Pill Organizers: Use a daily pillbox so you can easily verify if you took today’s dose.
  • Plan Ahead for Refills: Request refills when you still have a 7-day supply left, and bring your medications in their original labeled containers when traveling.

Common questions in this guide

What should I do if I miss one antiplatelet dose after a heart attack or stent?
Do not panic or automatically take two pills at once. Check the instructions for your exact medicine and how long ago the dose was due, or call a pharmacist for guidance because missed-dose advice differs by drug and schedule.
Should I take an extra antiplatelet pill to catch up?
No. Do not take an extra antiplatelet pill unless your clinician specifically tells you to. Instructions differ for aspirin, clopidogrel, ticagrelor, and prasugrel and depend on whether the medicine is taken once or twice daily.
What should I do if I miss several doses or run out of medication?
Contact your prescribing doctor or cardiology team immediately if you miss more than one dose or cannot obtain a refill. After hours, use the on-call service or urgent care, and ask a pharmacist whether an emergency supply is possible. Do not borrow medication or switch drugs.
What if I accidentally take an extra antiplatelet dose?
Contact your pharmacist, prescribing team, or local poison control center promptly for individualized advice. Do not skip your next scheduled dose unless a healthcare professional tells you to.
Can I stop antiplatelet medicine for dental work, surgery, or bruising?
Do not stop aspirin or your second antiplatelet drug on your own for dental work, surgery, or minor bruising. Your cardiology team should coordinate any planned interruption with the dentist or surgeon.
How long should I take dual antiplatelet therapy after a stent or heart attack?
The length of dual antiplatelet therapy is individualized based on your heart history, bleeding risk, and stent type. Ask your cardiology team for your planned end date, and do not assume it is safe to stop after a few months.
When should I call 911 after missing an antiplatelet dose?
Call 911 or your local emergency number for new or returning chest pain, pressure, or tightness; trouble breathing; fainting; or signs of severe bleeding such as vomiting blood or black stools. Do not drive yourself to the hospital.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on acute myocardial infarction.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Whom should I contact after hours or on weekends if I run out of my medication or miss multiple doses?
  2. 2.How long am I specifically scheduled to remain on this dual antiplatelet therapy, and what factors might change that planned end date?
  3. 3.What is the exact plan for my medication if I experience side effects like severe bruising, or if I have a stomach bug and throw up a dose?
  4. 4.How can we manage the cost of these medications if my insurance changes or they become too expensive to refill?

References

References (16)
  1. 1

    Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.

    Capodanno D, Mehran R, Krucoff MW, et al.

    Circulation 2023; (147(25)):1933-1944 doi:10.1161/CIRCULATIONAHA.123.064473.

    PMID: 37335828
  2. 2

    Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.

    Gimbel M, Qaderdan K, Willemsen L, et al.

    Lancet (London, England) 2020; (395(10233)):1374-1381 doi:10.1016/S0140-6736(20)30325-1.

    PMID: 32334703
  3. 3

    What should patients do if they miss a dose of medication? A theoretical approach.

    Counterman ED, Lawley SD

    Journal of pharmacokinetics and pharmacodynamics 2021; (48(6)):873-892 doi:10.1007/s10928-021-09777-6.

    PMID: 34506001
  4. 4

    In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project.

    Zhao G, Zhou M, Ma C, et al.

    Journal of the American Heart Association 2018; (7(7)) doi:10.1161/JAHA.117.008100.

    PMID: 29602767
  5. 5

    Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology.

    Gorog DA, Ten Berg JM, Campo G, et al.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2026; (22(12)):e653-e677 doi:10.4244/EIJ-E-26-00003.

    PMID: 42290315
  6. 6

    Precision Management of Coronary Stent Thrombosis: A Contemporary Guide.

    Attachaipanich T, Rizwan A, Virk HUH, et al.

    Current cardiology reports 2026; (28(1)):9 doi:10.1007/s11886-025-02343-3.

    PMID: 41489659
  7. 7

    Prasugrel in the treatment of acute coronary syndrome.

    Spartalis M, Tzatzaki E, Spartalis E, et al.

    Future cardiology 2020; (16(6)):559-568 doi:10.2217/fca-2020-0018.

    PMID: 32390477
  8. 8

    Patient-Related Factors Predicting Stent Thrombosis in Percutaneous Coronary Interventions.

    Anghel L, Tudurachi BS, Tudurachi A, et al.

    Journal of clinical medicine 2023; (12(23)) doi:10.3390/jcm12237367.

    PMID: 38068419
  9. 9

    Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome).

    Fosbøl EL, Ju C, Anstrom KJ, et al.

    Circulation. Cardiovascular interventions 2016; (9(11)).

    PMID: 27789517
  10. 10

    Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES.

    Brodie BR, Garg A, Stuckey TD, et al.

    Circulation. Cardiovascular interventions 2015; (8(10)).

    PMID: 26415600
  11. 11

    De-escalation strategies in patients with acute coronary syndrome: a step towards precision medicine.

    Gragnano F, Capolongo A, Terracciano F, et al.

    Expert review of cardiovascular therapy 2023; (21(7)):545-551 doi:10.1080/14779072.2023.2221851.

    PMID: 37267100
  12. 12

    Insight into the Time Course of Type III Kounis Syndrome: A Case Report.

    Watanabe S, Sakai C, Hori M, Kawasaki T

    The Journal of emergency medicine 2020; (59(2)):e65-e68 doi:10.1016/j.jemermed.2020.04.054.

    PMID: 32536494
  13. 13

    Broken heart after heart attack- post-MI Takotsubo syndrome: a case report.

    Kassam N, Mucyo W, Ngunga M, et al.

    The Pan African medical journal 2025; (51()):101 doi:10.11604/pamj.2025.51.101.43609.

    PMID: 41116822
  14. 14

    Acute coronary stent thrombosis: A case of type 3 Kounis syndrome.

    Tripolino C, Tassone EJ, Morabito G, et al.

    Journal of cardiology cases 2019; (19(1)):33-35 doi:10.1016/j.jccase.2018.09.003.

    PMID: 30693057
  15. 15

    Control of acute phase intestinal bleeding after percutaneous coronary intervention by discontinuing dual antiplatelet therapy and implementing intra-aortic balloon pumping.

    Nakabayashi K, Higashitani M

    Journal of cardiology cases 2015; (11(4)):113-116 doi:10.1016/j.jccase.2014.12.004.

    PMID: 30546544
  16. 16

    Pulmonary alveolar hemorrhage mimicking a pneumopathy: a rare complication of dual antiplatelet therapy for ST elevation myocardial infarction.

    Oualim S, Elharda CA, Benzeroual D, Hattaoui ME

    The Pan African medical journal 2016; (24()):308 doi:10.11604/pamj.2016.24.308.8828.

    PMID: 28154663

This page provides general information about missed antiplatelet doses and is not medical advice. Your cardiology team or pharmacist should give instructions for your specific medicine, timing, stent, and bleeding risk.